RecruitingNCT06037967

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders


Sponsor

University Hospital, Toulouse

Enrollment

3,200 participants

Start Date

Feb 28, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to build up a clinico-biological bank of samples from patients suspected of or suffering from allergic diseases (including asthma) or mast cell diseases in order to support future research in the field of allergic diseases. The biobank will help to identify new prognostic, diagnostic and/or predictive biomarkers.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria8

  • patients with a positive prick test or specific IgE regardless of the allergen
  • patients suspected of allergic pathology defined by the need to carry out a prick test or specific IgE or a food or drug reintroduction test as part of the treatment
  • patients with systemic or cutaneous mastocytosis according to the international classification8
  • patients with mast cell activation syndrome according to the international classification8
  • patients with familial hyper-alpha tryptasemia on the presence of variation in the number of copies of the alpha allele of the TPSAB1 gene
  • patients with asthma of any severity
  • people affiliated or beneficiaries of a social security scheme
  • patients able to receive and understand the information on the study and their participation and having freely consented to it in writing before any collection of samples or data necessary for the research (no restriction of rights by the judicial authorities and mastery of the French language).

Exclusion Criteria2

  • patients under legal protection, guardianship or curatorship
  • pregnant or breastfeeding women

Locations(1)

Laurent GUILLEMINAULT

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06037967


Related Trials